Currently, there are 435.31M common shares owned by the public and among those 433.76M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -3.90% and -27.54% over the past three months. CCJ shares are trading -18.49% year to date (YTD), with the 12-month market performance up to 3.36% higher. It has a 12-month low price of $35.43 and touched a high of $62.55 over the same period. CCJ has an average intraday trading volume of 4.25 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -10.11%, -15.54%, and -15.49% respectively.
Institutional ownership of Cameco Corp (NYSE: CCJ) shares accounts for 76.14% of the company’s 435.31M shares outstanding.
It has a market capitalization of $18.24B and a beta (3y monthly) value of 1.04. The stock’s trailing 12-month PE ratio is 147.81, while the earnings-per-share (ttm) stands at $0.28. The company has a PEG of 2.75 and a Quick Ratio of 0.92 with the debt-to-equity ratio at 0.20. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.61% over the week and 4.72% over the month.
Analysts forecast that Cameco Corp (CCJ) will achieve an EPS of 0.21 for the current quarter, 0.29 for the next quarter and 2.3 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.03 while analysts give the company a high EPS estimate of 0.03. Comparatively, EPS for the current quarter was 0.13 a year ago. Earnings per share for the fiscal year are expected to increase by 100.71%, and 69.30% over the next financial year. EPS should grow at an annualized rate of 53.76% over the next five years, compared to 15.41% over the past 5-year period.
Goldman coverage for the Cameco Corp (CCJ) stock in a research note released on April 01, 2024 offered a Buy rating with a price target of $55. BMO Capital Markets on their part issued Outperform rating on November 08, 2023.
